TrialStroke2025

Apixaban and Recurrent Stroke Risk With Left Ventricular Dysfunction: A Secondary Analysis of the ARCADIA Trial.

Richa Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.